Reversible inhibition of sperm receptor synthesis for contraception
AssigneesThe Penn State Research Foundation, Pharma Science, Inc.
InventorsGUY F. BARBATO, ALEXANDER MACDONALD
Life of this patent
Estimating the term…
Abstract
Methods are disclosed for reversibly inhibiting sperm receptor activity in animals. Nicarbazin, its derivatives and modifications which retain pharmacological activity are shown to inhibit activity of zona pellucida proteins and concomitant synthesis and/or assembly of the sperm receptor on the oocyte surface necessary for fertilization. Nicarbazin is easily administered, for example by simple addition to feed of an animal and is and non-toxic to the animals, providing a safe and efficient means for controlling populations of mammals and avian species.
Claims21
A method of reversibly inhibiting sperm receptor synthesis and assembly in animals comprising:
- administering to said animals an effective amount of nicarbazin and a carrier,
- verifying inhibition of zona pellucida protein C (ZPC) in said animals, and
- stopping administration to said animals to reversibly restore ZPC in said animals.
A method of reversibly inhibiting sperm receptor synthesis and assembly in mammals comprising:
- administering to a mammal in need of contraception an effective amount of nicarbazin and a carrier,
- inhibiting zona pellucida protein C (ZPC) in said mammal, and
- stopping administration to said mammals to reversibly restore ZPC in said mammals to restore fertility and allow said mammals to produce offspring.
Dependencies are inferred from the claim text.